System and a method for automatically managing continuous glucose monitoring measurements indicative of glucose level in a bodily fluid
AssigneeRoche Diabetes Care, Inc.
InventorChristian Ringemann
Life of this patent
Estimating the term…
Abstract
The disclosure relates to a method and system for controlling glucose levels comprising receiving behavioral sensor measurements and analyte sensor measurements, determining a plurality of analyte profiles from continuous analyte sensor measurements; grouping the plurality of analyte profiles into clusters; assigning a selected behavioral parameter or a selected pattern of behavioral parameters to each analyte profile in a first cluster, and providing a treatment recommendation.
Claims18
A method of managing glucose levels in a body fluid, comprising:
- a) receiving continuous glucose measurements from a glucose sensor;
- b) receiving behavioral measurements from one or more behavioral sensors and associating the behavioral measurements with one or more behavioral parameters;
- c) dividing the continuous glucose measurements into a plurality of glucose profiles wherein each of the plurality of glucose profiles covers a different time interval;
- d) grouping the plurality of glucose profiles into at least a first cluster and a second cluster different from the first cluster using a clustering parameter that comprises a clinically relevant parameter wherein the clinically relevant parameter is selected from the following group:
- parameters indicating one of hypoglycemia, nocturnal hypoglycemia, hyperglycemia, post-hypoglycemic hyperglycemia, and glucose variability;
- e) assigning a selected one of the one or more behavioral parameters to a first subset of the plurality of glucose profiles but not to all of the plurality of glucose profiles and wherein each glucose profile in the first cluster is a member of the first subset, but less than all of the glucose profiles in the second cluster is a member of the first subset;
- f) presenting the selected one of the one or more behavioral parameters and the first cluster;
- and
- g) generating a treatment recommendation based upon an analysis of the results of step f) to prevent hyperglycemia wherein the treatment recommendation is an insulin bolus and administering the insulin bolus.
A method of managing glucose levels in a body fluid, comprising:
- a) receiving continuous glucose measurements from a glucose sensor;
- b) receiving behavioral measurements from one or more behavioral sensors and associating the behavioral measurements with one or more behavioral parameters;
- c) dividing the continuous glucose measurements into a plurality of glucose profiles wherein each of the plurality of glucose profiles covers a different time interval;
- d) grouping the plurality of glucose profiles into at least a first cluster and a second cluster different from the first cluster using a clustering parameter that comprises a clinically relevant parameter wherein the clinically relevant parameter is selected from the following group:
- parameters indicating one of hypoglycemia, nocturnal hypoglycemia, hyperglycemia, post-hypoglycemic hyperglycemia, and glucose variability;
- e) assigning a selected one of the one or more behavioral parameters to a first subset of the plurality of glucose profiles but not to all of the plurality of glucose profiles and wherein each glucose profile in the first cluster is a member of the first subset, but less than all of the glucose profiles in the second cluster is a member of the first subset;
- f) presenting the selected one of the one or more behavioral parameters and the first cluster;
- and
- g) generating a treatment recommendation based upon an analysis of the results of step f) to prevent hypoglycemia wherein the treatment recommendation is an ingestion of food and administering the ingestion of food.
A method of managing glucose levels in a body fluid, comprising:
- a) receiving continuous glucose measurements from a glucose sensor;
- b) receiving behavioral measurements from one or more behavioral sensors and associating the behavioral measurements with one or more behavioral parameters;
- c) dividing the continuous glucose measurements into a plurality of glucose profiles wherein each of the plurality of glucose profiles covers a different time interval;
- d) grouping the plurality of glucose profiles into at least a first cluster and a second cluster different from the first cluster using a clustering parameter that comprises a level of similarity between the glucose profiles;
- e) assigning a selected one of the one or more behavioral parameters to a first subset of the plurality of glucose profiles but not to all of the plurality of glucose profiles and wherein each glucose profile in the first cluster is a member of the first subset, but less than all of the glucose profiles in the second cluster is a member of the first subset;
- f) presenting the selected one of the one or more behavioral parameters and the first cluster;
- and
- g) creating an ambulatory glucose profile for at least one of the first cluster and the second cluster and generating a treatment option wherein the treatment option is determined based upon an analysis of the ambulatory glucose profile to prevent hyperglycemia wherein the treatment option is an insulin bolus and administering the insulin bolus.
A method of managing glucose levels in a body fluid, comprising:
- a) receiving continuous glucose measurements from a glucose sensor;
- b) receiving behavioral measurements from one or more behavioral sensors and associating the behavioral measurements with one or more behavioral parameters;
- c) dividing the continuous glucose measurements into a plurality of glucose profiles wherein each of the plurality of glucose profiles covers a different time interval;
- d) grouping the plurality of glucose profiles into at least a first cluster and a second cluster different from the first cluster using a clustering parameter that comprises a level of similarity between the glucose profiles;
- e) assigning a selected one of the one or more behavioral parameters to a first subset of the plurality of glucose profiles but not to all of the plurality of glucose profiles and wherein each glucose profile in the first cluster is a member of the first subset, but less than all of the glucose profiles in the second cluster is a member of the first subset;
- f) presenting the selected one of the one or more behavioral parameters and the first cluster;
- and
- g) creating an ambulatory glucose profile for at least one of the first cluster and the second cluster and generating a treatment option wherein the treatment option is determined based upon an analysis of the ambulatory glucose profile to prevent hypoglycemia wherein the treatment option is the consumption of food and administering the consumption of food.
A glucose management system, comprising:
- a medication delivery device;
- and
- a processor configured to:
- a) receive continuous glucose measurements measured with a glucose sensor;
- b) receive behavioral measurements measured with one or more behavioral sensors, and associate the behavioral measurements with one or more behavioral parameters;
- c) divide the continuous glucose measurements into a plurality of glucose profiles wherein each of the plurality of glucose profiles covers a different time interval;
- d) group the plurality of glucose profiles into at least a first cluster and a second cluster different from the first cluster using i) a clustering parameter that comprises a level of similarity between the glucose profiles and/or ii) a clustering parameter that comprises a clinically relevant parameter wherein the clinically relevant parameter is selected from the following group:
- parameters indicating one of hypoglycemia, nocturnal hypoglycemia, hyperglycemia, post-hypoglycemic hyperglycemia, and glucose variability;
- e) assign a selected one of the one or more behavioral parameters to each glucose profile in the first cluster, but less than all of the glucose profiles in the second cluster;
- f) present the selected one of the one or more behavioral parameters and the first cluster;
- and
- g) generate a treatment option and a recommended time for administering the treatment option wherein the treatment option and the recommended time are determined based upon an analysis of an ambulatory glucose profile determined for the first cluster and wherein the treatment option is an insulin bolus and the glucose management system is further configured to automatically administer the insulin bolus with the medication delivery device at the recommended time.
Dependencies are inferred from the claim text.